Oncology for the Inquisitive Mind
by Michael Fernando and Josh Hurwitz
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 7 chart positions in 7 markets.
By chart position
- 🇲🇽MX · Medicine#9110K to 30K
- 🇳🇿NZ · Medicine#1430K to 100K
- 🇭🇺HU · Medicine#3710K to 30K
- 🇳🇬NG · Medicine#923K to 10K
- 🇷🇴RO · Medicine#963K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
17K to 56K🎙 Daily cadence·215 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
57K to 186K🇳🇿54%🇲🇽16%🇭🇺16%+4 more - Active Followers
Loyal subscribers who consistently listen
17K to 56K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 20 epsHosts
Recent guests
Recent episodes
208. ASCO 2026 - The Plenary Episode - Part 3
Jul 12, 2026
52m 54s
207. ASCO 2026 - Agents of the Future - Part 2
Jul 5, 2026
1h 04m 25s
206. ASCO 2026 - Part 1
Jun 28, 2026
1h 01m 50s
205. ESTRO update with A/Prof Steven David
Jun 14, 2026
22m 39s
204. Jake Messier on Living with Metastatic Male Breast Cancer
Jun 7, 2026
43m 58s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/12/26 | oncologyclinical trials+4 | — | abemacicilibivonescimab+4 | — | oncologyclinical trials+8 | — | 52m 54s | ||
| 7/5/26 | ASCO 2026cancer trials+4 | — | GLP-1 agonistOrigAMI-4+8 | breast cancerhead and neck cancer+3 | cancer trialsASCO 2026+5 | Pfizer | 1h 04m 25s | ||
| 6/28/26 | ASCO 2026cancer trials+5 | — | pan-PI3K inhibitorsantibody drug conjugates+1 | uvel melanomaHR +ve Breast Cancer+7 | ASCO 2026cancer trials+7 | Pfizer | 1h 01m 50s | ||
| 6/14/26 | breast cancerradiation therapy+3 | A/Prof Steven David | European Society for Radiotherapy and OncologyArchery Trial+1 | Stockholm, Sweden | breast cancerradiation therapy+3 | Pfizer | 22m 39s | ||
| 6/7/26 | metastatic male breast cancerstigma+4 | Jake Messier | Oncology for the Inquisitive Mindwww.inquisitiveonc.com+2 | — | metastatic breast cancermale breast cancer+5 | Pfizer | 43m 58s | ||
| 5/31/26 | pancreatic cancerneoadjuvant chemotherapy+4 | — | Oncology for the Inquisitive Mind | — | pancreatic cancerESPAC4+6 | Pfizer | 25m 30s | ||
| 5/24/26 | advanced pancreatic cancertreatment options+5 | — | liposomal irinotecanNALIRIFOX+2 | — | pancreatic cancertreatment+5 | Pfizer | 22m 27s | ||
| 5/17/26 | advanced gastric cancerGOJ cancer+4 | — | trastuzumab deruxtecan | — | gastric cancerGOJ cancer+6 | Pfizer | 28m 21s | ||
| 5/9/26 | gastric cancerimmunotherapy+3 | — | FLOT4-AIOMATTERHORN+1 | — | gastric cancerimmunotherapy+5 | Pfizer | 29m 01s | ||
| 5/3/26 | metastatic colorectal cancertherapeutic options+5 | — | trifluridine-tipiracilLonsurf+2 | — | metastatic colorectal cancertrifluridine-tipiracil+6 | Pfizer | 23m 41s | ||
| 4/26/26 | oesophageal cancerchemotherapy+3 | — | ESOPECCheckmate 577 | — | oesophageal cancerchemotherapy+5 | Pfizer | 27m 38s | ||
| 4/18/26 | Metastatic Colorectal CancerHER2 positive disease+4 | — | trastruzumab deruxtecan | — | metastatic colorectal cancerHER2+5 | Pfizer | 39m 04s | ||
| 4/9/26 | metastatic colorectal cancerBRAF mutations+4 | — | — | — | metastatic colorectal cancerBRAF mutations+6 | Pfizer | 26m 36s | ||
| 3/28/26 | immunotherapymetastatic colorectal cancer+3 | — | pembrolizumabipilimumab+1 | — | colorectal cancerimmunotherapy+6 | Pfizer | 25m 50s | ||
| 3/21/26 | metastatic colorectal cancerchemotherapy+4 | — | cetuximabpanitumumab | — | metastatic colorectal cancerchemotherapy+6 | Pfizer | 26m 41s | ||
| 3/14/26 | genitourinary cancersmetastatic urothelial cancer+3 | Jonathan E. Rosenberg, MD | Memorial Sloan Kettering Cancer CentreWeill Cornell Medical College | — | urothelial cancerbladder cancer+3 | Pfizer | 37m 00s | ||
| 3/7/26 | colorectal cancerCTDNA+4 | — | ipilimumabnivolumab | — | colorectal cancerCTDNA+5 | Pfizer | 23m 30s | ||
| 2/28/26 | colorectal canceradjuvant regimen+3 | — | IDEASTransMET+1 | — | colorectal cancerFOLFOX+6 | Pfizer | 25m 48s | ||
| 2/21/26 | mesotheliomatreatment options+3 | — | MAPSCheckmate 743 | — | mesotheliomaipilimumab+5 | Pfizer | 18m 42s | ||
| 2/16/26 | extensive stage small cell lung cancernew treatments+3 | — | tarlatamablurbinectedin+2 | — | small cell lung cancertarlatamab+6 | Pfizer | 21m 18s |
Showing 20 of 20
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Oncology for the Inquisitive Mind
Peaked at #14 in New Zealand, currently #14 in New Zealand.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| New Zealand | — | #14 | #14 | — |
| HU | — | #37 | #37 | — |
| New Zealand | — | #77 | #77 | — |
| Mexico | — | #91 | #91 | — |
| NG | — | #92 | #92 | — |
| RO | — | #96 | #96 | — |
| TW | — | #176 | #176 | — |
| HK | — | #191 | #191 | — |
Chart Positions
8 placements across 7 markets.
Chart Positions
8 placements across 7 markets.